articleTop 1% cited

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

The Lancet · 2002 · Vol. 360(9326) · pp. 7–22

Lipoproteins and Cardiovascular Health Cardiac Imaging and Diagnostics Health Systems, Economic Evaluations, Quality of LifeSimvastatinMedicinePlaceboInternal medicineStatinCholesterolDiabetes mellitusCardiologyVascular diseaseRandomized controlled trial

MeSH terms

AdultAgedAged, 80 and overAnticholesteremic AgentsCause of DeathCoronary DiseaseDiabetes MellitusFemaleFollow-Up StudiesUnited KingdomHumansCholesterol, LDLMaleMiddle AgedMyocardial Infarction

Funding

Medical Research Council

Citations

6,993

FWCI

545.98

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Stroke Risk Factors, Genetics, and Prevention

Circulation Research · 2017 · 1,866 citations

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

Circulation · 2004 · 6,919 citations

Myeloperoxidase and Cardiovascular Disease

Arteriosclerosis Thrombosis and Vascular Biology · 2005 · 781 citations

Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication

Journal of Vascular Surgery · 2015 · 889 citations

Pleiotropic Effects of Statins on the Cardiovascular System

Circulation Research · 2017 · 1,174 citations

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Atherosclerosis · 2016 · 1,581 citations

Statins for the primary prevention of cardiovascular disease

Cochrane Database of Systematic Reviews · 2013 · 1,829 citations

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Journal of the American College of Cardiology · 2013 · 3,832 citations

References

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

New England Journal of Medicine · 2000 · 8,641 citations

Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2

Atherosclerosis · 1998 · 1,262 citations

Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

Diabetes Care · 1993 · 4,087 citations

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

BMJ · 2002 · 6,935 citations

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

British Journal of Cancer · 1977 · 8,398 citations

Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

Clinical Chemistry · 1972 · 32,293 citations

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

JAMA · 1993 · 27,890 citations

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels

JAMA · 1998 · 5,284 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.